Biocryst Pharmaceuticals (BCRX) Receivables: 2010-2014
Historic Receivables for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $3.8 million.
- Biocryst Pharmaceuticals' Receivables rose 131.47% to $7.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $21.2 million, marking a year-over-year increase of 122.81%. This contributed to the annual value of $3.8 million for FY2014, which is 81.99% up from last year.
- According to the latest figures from FY2014, Biocryst Pharmaceuticals' Receivables is $3.8 million, which was up 81.99% from $2.1 million recorded in FY2013.
- Biocryst Pharmaceuticals' 5-year Receivables high stood at $30.2 million for FY2010, and its period low was $2.1 million during FY2013.
- Its 3-year average for Receivables is $5.0 million, with a median of $3.8 million in 2014.
- In the last 5 years, Biocryst Pharmaceuticals' Receivables tumbled by 76.82% in 2013 and then skyrocketed by 81.99% in 2014.
- Biocryst Pharmaceuticals' Receivables (Yearly) stood at $30.2 million in 2010, then crashed by 61.42% to $11.7 million in 2011, then dropped by 21.76% to $9.1 million in 2012, then plummeted by 76.82% to $2.1 million in 2013, then soared by 81.99% to $3.8 million in 2014.